These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 22240843)

  • 1. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
    Onoue S; Kojo Y; Aoki Y; Kawabata Y; Yamauchi Y; Yamada S
    Drug Metab Pharmacokinet; 2012; 27(4):379-87. PubMed ID: 22240843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel solid dispersion of tranilast using amphiphilic block copolymer for improved oral bioavailability.
    Onoue S; Kojo Y; Suzuki H; Yuminoki K; Kou K; Kawabata Y; Yamauchi Y; Hashimoto N; Yamada S
    Int J Pharm; 2013 Aug; 452(1-2):220-6. PubMed ID: 23694807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and in vitro/in vivo characterization of tranilast-AMP clay complex for improving drug dissolution and bioavailability.
    Yang L; Shao Y; Han HK
    Arch Pharm Res; 2014 Dec; 37(12):1554-9. PubMed ID: 25119994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach.
    Onoue S; Sato H; Ogawa K; Kawabata Y; Mizumoto T; Yuminoki K; Hashimoto N; Yamada S
    Int J Pharm; 2010 Oct; 399(1-2):94-101. PubMed ID: 20705124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved dissolution and pharmacokinetic behavior of dipyridamole formulation with microenvironmental pH-modifier under hypochlorhydria.
    Onoue S; Inoue R; Taniguchi C; Kawabata Y; Yamashita K; Wada K; Yamauchi Y; Yamada S
    Int J Pharm; 2012 Apr; 426(1-2):61-66. PubMed ID: 22266536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical and Pharmacokinetic Characterization of Amorphous Solid Dispersion of Meloxicam with Enhanced Dissolution Property and Storage Stability.
    Ochi M; Kimura K; Kanda A; Kawachi T; Matsuda A; Yuminoki K; Hashimoto N
    AAPS PharmSciTech; 2016 Aug; 17(4):932-9. PubMed ID: 27435198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption improvement of tranilast by forming highly soluble nano-size composite structures associated with α-glucosyl rutin via spray drying.
    Sato H; Fujimori M; Suzuki H; Kadota K; Shirakawa Y; Onoue S; Tozuka Y
    Eur J Pharm Biopharm; 2015 May; 92():49-55. PubMed ID: 25725261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced biopharmaceutical effects of tranilast on experimental colitis model with use of self-micellizing solid dispersion technology.
    Kojo Y; Suzuki H; Kato K; Kaneko Y; Yuminoki K; Hashimoto N; Sato H; Seto Y; Onoue S
    Int J Pharm; 2018 Jul; 545(1-2):19-26. PubMed ID: 29702241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro/in vivo characterization of nanocrystalline formulation of tranilast with improved dissolution and hepatoprotective properties.
    Onoue S; Yamamoto K; Kawabata Y; Yamada S
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):952-7. PubMed ID: 24055688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: a successful approach to improve the bioavailability of atorvastatin.
    Salmani JM; Lv H; Asghar S; Zhou J
    Pharm Dev Technol; 2015 Jun; 20(4):465-72. PubMed ID: 24490758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability.
    Kawabata Y; Yamamoto K; Debari K; Onoue S; Yamada S
    Eur J Pharm Sci; 2010 Feb; 39(4):256-62. PubMed ID: 20038453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
    Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
    Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects.
    Onoue S; Nakamura T; Uchida A; Ogawa K; Yuminoki K; Hashimoto N; Hiza A; Tsukaguchi Y; Asakawa T; Kan T; Yamada S
    Eur J Pharm Sci; 2013 Jul; 49(4):453-60. PubMed ID: 23707470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
    Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
    Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion.
    Zhang Y; Luo R; Chen Y; Ke X; Hu D; Han M
    AAPS PharmSciTech; 2014 Jun; 15(3):560-8. PubMed ID: 24570374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability.
    Onoue S; Takahashi H; Kawabata Y; Seto Y; Hatanaka J; Timmermann B; Yamada S
    J Pharm Sci; 2010 Apr; 99(4):1871-81. PubMed ID: 19827133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and Evaluation of Hot-Melt Extruded Patient-Centric Ketoprofen Mini-Tablets.
    Alshetaili AS; Almutairy BK; Tiwari RV; Morott JT; Alshehri SM; Feng X; Alsulays BB; Park JB; Zhang F; Repka MA
    Curr Drug Deliv; 2016; 13(5):730-41. PubMed ID: 26456211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
    Sathigari SK; Radhakrishnan VK; Davis VA; Parsons DL; Babu RJ
    J Pharm Sci; 2012 Sep; 101(9):3456-64. PubMed ID: 22437488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.